NEWS HealthCare2U Platform Released Nov 18, 2015 OTC

New Post Public Reply Private Reply Replies (0) Message Board
SilentSniper
NEWS

HealthCare2U Platform Released
Nov 18, 2015
OTC Disclosure & News Service

Boerne, TX - We are pleased to announce Oak River Technology Development Team has rolled out the production platform for HealthCare2U (HC2U) today, November 18, 2015
"This provides HealthCare2U with their own customized agent/broker network enrollment and premiums administration solution platform. The Oak River Technology unique ability to integrate and share data with payroll companies, HR Software's etc. simplifies agents being able to add HC2U to their existing customer benefits portfolio without additional burden or data requirments." Kent Linduff CEO Oak River Technology.
HC2U is a unique and popular low cost solution that is Affordable Care Act compliant. Average cost of $70 per month per individual is popular among the self employed and those who do not qualify for full time benefits with their employer.
HC2U has thousands of life's ready to put on the platform beginning immediately.
"This was a significant effort on both companies parts to make this happen. I could not be more pleased than to be working with Andy Bohner and his team for the long term" said Kent Linduff.

For more information please visit https://healthc2u.com/ or contact us @ investorrelations@oakrivertech.com

http://www.otcmarkets.com/stock/TDEY/news/Hea...00&b=y

STELLA DIAGNOSTICS INC. (SLDX) Stock Research Links

SLDX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investors Urged to Act as Lawsuit Against Everus Builds

Updated Category News Views 97

Investigation of Claims Against Everus Construction Group Faruqi & Faruqi, LLP, a well-respected national securities law firm, has initiated an investigation into potential claims associated with Everus Construction Group, Inc. (NYSE: ECG). The firm specializes in shareholder rights and is aiming to provide support to affected investors after concerning revelations about...

Continue Reading
Heilongjiang Forum 2025: Elevating Macao's Global Tourism Standing

Updated Category News Views 107

Global Tourism Economy Forum 2025: A Landmark Event The Global Tourism Economy Forum (GTEF) made its notable debut outside of Macao by hosting the 2025 edition in Heilongjiang province, China. This forum gathered influential figures from the tourism sector and various related industries, fostering discussions aimed at exploring new avenues for cooperation and growth....

Continue Reading
Nextracker and T1 Energy Collaboration Drives Solar Growth

Updated Category News Views 198

Nextracker and T1 Energy Join Forces to Strengthen Solar Production Nextracker Inc. (NASDAQ: NXT) has recently established a partnership with T1 Energy Inc. (NYSE: TE) aimed at revolutionizing solar manufacturing. This collaboration will see the integration of Nextracker's cutting-edge steel module frame technology into T1 Energy's upcoming solar manufacturing plant,...

Continue Reading
Nathan Ballentine Steps In as Regional VP at New American Funding

Updated Category News Views 175

New Leadership at New American Funding New American Funding (NAF), a prominent independent mortgage lender, has announced a significant appointment. Nathan Ballentine is joining the team as the Regional Vice President, where he will play a pivotal role in propelling growth and development within the state. His expertise will be crucial as the company seeks to deepen its...

Continue Reading
CSL Behring Secures Approval for ANDEMBRY® in Japan

Updated Category News Views 341

CSL Behring's Recent Approval for ANDEMBRY® CSL Behring has announced a significant medical milestone with the approval of ANDEMBRY® (garadacimab) subcutaneous (S.C.) injection 200mg pens in Japan. This groundbreaking therapy is a first-in-class monoclonal antibody specifically designed to inhibit activated Factor XII (FXIIa), a crucial initiator in the hereditary...

Continue Reading